RecruitingNCT05616559

Precision Medicine in the Depression Treatment

The BrainDrugs-Depression Study: A Prospective Precision Psychiatry Cohort Study in the Treatment of Depression


Sponsor

Rigshospitalet, Denmark

Enrollment

800 participants

Start Date

Jun 15, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The BrainDrugs-D study uses multimodal neuroimaging combined with self-report measures, clinical and molecular markers to identify clinically relevant predictors that can identify subtypes of major depressive disorder (MDD) and, in a naturalistic setting, predict treatment response to standard antidepressive treatment. The cohorts are followed in nationwide health registries.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is developing a precision medicine approach to depression treatment — using brain scans, blood tests, and detailed assessments — to better match patients with the most effective therapy for their individual profile. **You may be eligible if...** - You are between 18 and 65 years old - You have been diagnosed with a primary depressive episode (not caused by another condition) - You have been referred for treatment for a single episode of depression **You may NOT be eligible if...** - You have psychosis or psychotic symptoms - You have had a severe head injury - You have a brain tumor or a disease that causes changes to brain structure - You do not have enough Danish language skills to complete questionnaires and tests - For those in certain study groups: you are pregnant or breastfeeding, have contraindications to MRI, have had significant radiation exposure recently, or are taking psychiatric medications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTTreatment Package for First-Episode Depression

The outpatient 'treatment package' for first episode depression is a national uniform package designed by Mental Health Services in the Capital Region. The treatment package for first-episode depression is a program with manualized group CBT, psychoeducation of patients and relatives, and relapse prevention. Antidepressant medication and individual psychotherapy are available as needed.


Locations(1)

Neurobiology Research Unit, Rigshospitalet

Copenhagen, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05616559


Related Trials